Tokyo, Nov. 10 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059699) titled 'Observational Study on the Efficacy and Adverse Effects of Foslevodopa Foscarbidopa Continuous Subcutaneous Infusion (FOCS)' on Nov. 8.
Study Type:
Observational
Primary Sponsor:
Institute - National Center of Neurology and Psychiatry
Condition:
Condition - Parkinson's disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This retrospective chart review included patients who received Foslevodopa Foscarbidopa Continuous Subcutaneous Infusion (FOCS) at our hospital, with the objective of identifying and characterizing issues arising during the clinical management ...